King Charles in hospital for prostate treatment
The King visits the Princess of Wales, who had surgery at the same hospital, ahead of his treatment.
Similar Posts
Agonising headaches make me bang my head off walls
Daren Frankish says his cluster headaches are like being hit with a baseball bat and stabbed in the eye.
Arkansas man receives world’s first eye transplant
Aaron James lost his nose, mouth and left eye in a work-related accident. Surgeons in New York successfully performed the reconstruction that included a whole-eye implant. His vision was not restored, but the first-of-its-kind procedure may help advance transplant medicine. “If some form of vision restoration occurred, it would be wonderful, but… the goal was…
Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: ‘We’re making progress’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Get measles vaccine to avoid rapid spread, says UK health boss
People have forgotten how miserable it is to have measles, a top health official warns.
Ozempic and Wegovy could lead to muscle loss, experts say, but prevention is possible
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…